Philips and Definiens Sign Memorandum of Understanding to Join Forces in Digital Pathology

| March 18, 2010

Washington D.C., USA – Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Definiens, a Germany-based company specializing in image analysis solutions, today announced that they have signed a memorandum of understanding to jointly develop and market clinical decision support solutions for digital pathology.

Full Press release at:

Category: Digital Pathology News, Pathology News

Comments are closed.